Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates
Azitra Inc (AZTR)
Company Research
Source: Business Wire
BRANFORD, Conn.--(BUSINESS WIRE)--Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today reported financial results for the full year ended December 31, 2023, and provided a business update.FY 2023 and Recent Business HighlightsCompleted an initial public offering, raising $7.5 million in gross proceeds.Obtained IND clearance of ATR-12 for a Phase 1b clinical trial in Netherton syndrome.Completed and filed post-IND, FDA commitments for characterization of drug substance and drug product for ATR-12.Selected and hired clinical research organization for ATR-12 clinical trial and selected initial clinical sites for activation.Advanced ATR-04 into IND-enabling studies.Advanced Bayer Joint Development Agreement and discussions with Bayer for a license agreement.Strengthened IP portfolio with U.S. patent issuance from the USPTO for treating skin diseases with recombinant microorganisms, in
Show less
Read more
Impact Snapshot
Event Time:
AZTR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZTR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZTR alerts
High impacting Azitra Inc news events
Weekly update
A roundup of the hottest topics
AZTR
News
- Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting [Yahoo! Finance]Yahoo! Finance
- Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy MeetingBusiness Wire
- Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024Business Wire
- Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates [Yahoo! Finance]Yahoo! Finance
- Azitra, Inc. Announces Closing of Public OfferingBusiness Wire
AZTR
Sec Filings
- 4/29/24 - Form 10-K/A
- 4/1/24 - Form 4
- 3/15/24 - Form 8-K
- AZTR's page on the SEC website